Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives
Saved in:
| Published in: | ClinicoEconomics and Outcomes Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1870206739461177344 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | ClinicoEconomics and Outcomes Research |
| description | |
| discipline_display | Health and Safety |
| discipline_facet | Health and Safety |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:101113 |
| institution | FRELIP |
| journal_source_facet | ClinicoEconomics and Outcomes Research |
| last_indexed | 2026-07-09T03:35:33.692Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives Health and Safety General Health and Safety |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Health and Safety General Health and Safety |
| subject_facet | Health and Safety General Health and Safety |
| title | Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives |
| title_alt | Impacto financiero de la elección del tratamiento en la leucemia mieloide crónica: comparación de ITK de última generación frente a imatinib desde la perspectiva del paciente y del pagador Impact financier du choix du traitement dans la leucémie myéloïde chronique : comparaison des ITK de dernière génération versus imatinib du point de vue du patient et du payeur Impacto financeiro da escolha do tratamento na leucemia mieloide crônica: comparação entre TKIs de última geração e Imatinibe sob a perspectiva do paciente e do pagador |
| title_auth | Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives |
| title_es_txt | Impacto financiero de la elección del tratamiento en la leucemia mieloide crónica: comparación de ITK de última generación frente a imatinib desde la perspectiva del paciente y del pagador |
| title_fr_txt | Impact financier du choix du traitement dans la leucémie myéloïde chronique : comparaison des ITK de dernière génération versus imatinib du point de vue du patient et du payeur |
| title_full | Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives |
| title_fullStr | Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives |
| title_full_unstemmed | Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives |
| title_pt_txt | Impacto financeiro da escolha do tratamento na leucemia mieloide crônica: comparação entre TKIs de última geração e Imatinibe sob a perspectiva do paciente e do pagador |
| title_short | Financial Impact of Treatment Choice in Chronic Myeloid Leukemia: A Comparison of Later Generation TKIs versus Imatinib from Patient and Payer Perspectives |
| title_sort | financial impact of treatment choice in chronic myeloid leukemia: a comparison of later generation tkis versus imatinib from patient and payer perspectives |
| topic | Health and Safety General Health and Safety |
| url | https://www.dovepress.com/financial-impact-of-treatment-choice-in-chronic-myeloid-leukemia-a-com-peer-reviewed-fulltext-article-CEOR |